BiotechTube
Evren Technologies

Evren Technologies

San Francisco, United States· Est.
evrenvns.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Evren Technologies is a private, pre-revenue digital health company founded in 2021, pioneering non-invasive bioelectronic therapies for PTSD. Its core technology is the Phoenix CR, a portable taVNS device designed to deliver electrical stimulation to the vagus nerve via the ear, aiming to restore autonomic balance and alleviate PTSD symptoms. The company is currently seeking investment to fund the final stages of FDA clinical trials and go-to-market activities, targeting a significant and underserved mental health market.

PsychiatryNeurology

Technology Platform

Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) delivered via a portable bioelectronic device.

Opportunities

Targeting a large, underserved $18B PTSD treatment market with high unmet need, particularly within the veteran population.
A successful non-invasive device could expand into adjacent multi-billion dollar indications like anxiety, depression, and traumatic brain injury.

Risk Factors

High regulatory and clinical trial risk for an unproven device in a complex psychiatric indication.
The company is pre-revenue and dependent on raising capital to complete development, facing significant funding risk.
Competition from other neuromodulation and pharmacological therapies presents commercial challenges.

Competitive Landscape

Competition includes pharmaceutical standards of care (SSRIs), psychotherapy, and other neuromodulation devices like transcranial magnetic stimulation (TMS) for depression/PTSD and invasive VNS implants (e.g., from LivaNova). Other companies are also developing non-invasive VNS/tVNS devices for various indications, creating a crowded and innovative field.

More companies in Neuroscience & CNS →More companies in United States →